Zenicor Zenicor Medical Systems AB has grown to become one of Sweden’s leading medtech companies in the fields of remote cardiology diagnostics and stroke prevention. Zenicor has developed a unique system, Zenicor-ECG, to detect and diagnose atrial fibrillation and other arrhythmias simply and cost-effectively. READ MORE ABOUT ZENICOR English Svenska Deutsch Suomi Zenicor-ECG News Research About Zenicor Contact Zenicor Zenicor-ECG Use cases Customer references Patient cases Product information Research reports Arrhythmia investigations Primary stroke prevention Secondary stroke prevention Cost-effectiveness List of references News Calendar About Zenicor Medical background Zenicor today The history of Zenicor Board of Directors Job vacancies Press material Contact Contact form Site map Zenicor Zenicor Medical Systems AB has grown to become one of Sweden’s leading medtech companies in the fields of remote cardiology diagnostics and stroke prevention. Zenicor has developed a unique system, Zenicor-ECG, to detect and diagnose atrial fibrillation and other arrhythmias simply and cost-effectively. READ MORE ABOUT ZENICOR Spotting AF Stopping stroke Stroke prevention at Queen Alexandra Hospital in Portsmouth In a project from Queen Alexandra Hospital, Portsmouth Hospital NHS trust, UK, 71 Stroke and TIA patients were investigated for Paroxysmal Atrial Fibrillation (PAF), using Zenicor thumb-ECG for 3 weeks in combination with continuous 24 hours Holter ECG. With Zenicor thumb-ECG 14 % of the patients were diagnosed with PAF, but only 7 % were detected with the Holter ECG. READ MORE Fit for small hearts and small thumbs Zenicor-ECG is currently used at more than 50 paediatric cardiology clinics in the Nordic region and Germany. The advantage of Zenicor-ECG is its simplicity. It\'s non invasive and there\'s no need for fixed chest electrodes. The patient can easily take Zenicor-ECG with them to school or sports activities. After a hospital visit, the patient takes the device home with them for as long an investigation period as is necessary – sometimes several months. READ MORE Easier than ever Up to half of patients may only feel the effects of their arrhythmia after one to three weeks, which is why Zenicor-ECG is a uniquely effective method. The simplicity and convenience for the patient means that the investigation can be performed over a longer period. A clinically verified method with proven efficacy and simplicity. READ MORE The Zenicor solution Zenicor’s products and solutions enable simple and effective diagnosis of atrial fibrillation and other cardiac arrythmias READ MORE ABOUT THE ZENICOR SOLUTION News Twice as many British stroke patients received a correct diagnosis with Zenicor-ECG In a recently completed project at Queen Alexandra hospital in Portsmouth twice as many stroke patients received the correct Atrial Fibrillation diagnosis with Zenicor-ECG compared to current standard of care. The aim of the project was to develop and improve the diagnosis of Atrial Fibrillation for stroke patients in Portsmouth and to prevent recurrent strokes. The study was presented at the European Stroke Organisation Conference in Venice. Published: 2016-06-30 Published by: zenicor Read article Zenicor purchasing partner to BNK Service Zenicor now listed by BNK Service as one of eight selected purchasing partners. Published: 2016-06-07 Published by: zenicor Read article First patients included in the STROKESTOP 2 study In April the first patients were included in the STROKESTOP 2 study. The aim of the study is to prevent stroke by screening for silent Atrial Fibrillation with Zenicor thumb-ECG and to initiate stroke preventive treatment. The study will include all 75 and 76 year old citizens in Stockholm. Published: 2016-05-16 Published by: zenicor Read article Over ten thousand 75-year-olds in Stockholm offered stroke prevention with Zenicor-ECG A new large study, STROKESTOP II, will be conducted during 2016 and 2017. Published: 2016-03-09 Published by: zenicor Read article ALL NEWS Calendar 9 – 12 October UK: Heart Rhythm Congress 12 – 13 October SE: Stroke Team 26 – 28 October FI: Neurologia Days 27 – 29 October NO: Cardiological autumn meeting 25 – 27 November DE: BNK Jahresabschlusstagung Show calendar © Zenicor Medical Systems AB News archive · Site map · Information about cookies · Publisher responsible · Follow us on ·